Fox Chase Cancer Center Welcomes Jessica Karen Wong

June 17, 2020

PHILADELPHIA (June 17, 2020) – Fox Chase Cancer Center announces the hiring of Jessica Karen Wong, MD, MEng, who will join the Department of Radiation Oncology as an assistant professor in the academic clinician track.

Wong will join the staff upon completion of her radiation oncology residency program at Fox Chase, where she served as chief resident last year and won the RSNA Roentgen Resident/Fellow Research Award.

Before attending medical school, Wong earned her masters of engineering in biomedical engineering from the Harvard-MIT Division of Health Sciences and Technology. She received her medical degree from the University of Tennessee College of Medicine on multiple scholarships.

She graduated with highest honors, was inducted into the Alpha Omega Alpha Medical Honors Society, and received the Faculty Medal for Academic Achievement and AOA Distinguished Graduate Awards.

Wong completed her internship in internal medicine at the University of Tennessee Health Science Center. She has technical radiation oncology experience in a number of areas, including external beam radiation therapy and brachytherapy. 

“We’re very excited that Dr. Wong will be joining our faculty in the Department of Radiation Oncology. Throughout her residency, she has demonstrated her clinical knowledge and compassion as well as her academic expertise in the treatment of prostate cancers and lymphomas, and she will be an asset to our department,” said Eric M. Horwitz, MD, FABS, FASTRO, chair of the Department of Radiation Oncology.

Wong is a member of the American Society for Radiation Oncology, American College of Radiation Oncology, Radiological Society of North America, and the Society of Women in Radiation Oncology.

She was a resident editor and radiation biology and radiation physics buildout contributor for RadOncQuestions. She has published multiple manuscripts and has had presentations at the American Radium Society Meeting and the American Society for Radiation Oncology Conference.

Wong will begin work at Fox Chase on July 1, 2020.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.


For more information, call 888-369-2427

Connect with Fox Chase